Impact of Proportional Assisted Ventilation on Dyspnea and Asynchrony in Mechanically Ventilated Patients (DYS-PAV)
Dyspnea
About this trial
This is an interventional treatment trial for Dyspnea focused on measuring Patient-ventilator interaction, Inspiratory muscles, Electromyogram, Mechanical ventilation, Proportional Assist Ventilation
Eligibility Criteria
Inclusion Criteria:
Patients will be included as soon as the meet the following criteria.
- Intubation and mechanical ventilation for a respiratory cause with severe hypoxemia defined as a PaO2 to FiO2 ratio <300 recorded at least once during the present ICU stay.
- PSV ventilation for > 6 hours.
Severe patient-ventilator disharmony defined by either
- a dyspnea ≥ 4 on a visual analogic scale (VAS) from 0 to 10 with respiratory rate ≥ 24 /minute and a drawing of neck muscles,
- or by an asynchrony index (IA) ≥ 10%, defined as = number of asynchrony events/total respiratory rate (ventilator cycles +wasted efforts) × 100
No improvement of disharmony despite an optimization of ventilator setting defined as follows.
- No improvement of dyspnea or double triggering despite an increase of the level of pressure support that should not generate a tidal volume > 10 ml/kg
- No improvement of ineffective efforts despite a decrease of the level of pressure support or generation of a dyspnea (defined as VAS>4) in response of the decrease of the level of pressure support.
- Decision of the physician in charge of the patient to switch mechanical ventilation from PSV mode to PAV.
- Remaining duration of mechanical ventilation estimated ≥ 24 hours.
- Patient able to communicate (Richmond Agitation and Sedation Scale between -1 and +1).
Exclusion Criteria:
Exclusion criteria will be as follows.
- Severe hypoxemia defined as a PaO2 to FiO2 ratio <150 mmHg.
- Delirium according to the CAM-ICU (1)
- Hemodynamic instability defined by the need for intravenous fluids or catecholamine during the previous 24 hours.
- Age <18 years; pregnant woman.
Sites / Locations
- Service de Pneumologie et Réanimation Médicale, Groupe Hospitalier Pitié Salpêtrière
Arms of the Study
Arm 1
Experimental
Ventilator settings, PAV
A first 30-minutes recording in PSV will be performed. Dyspnea-VAS, IC-RDOS will be measured at the beginning and at the end of this period. EMG and EEG will be recorded continuously. Patients will be subsequently switched to PAV. The PAV mode will be delivered by Puritan Bennett 980 ventilator (Covidien, Boulder, USA). Levels of PEEP and FiO2 will be kept constant. The level of assistance in PAV, named %-assistance will be set in order to keep the patient in a respiratory effort zone corresponding to a respiratory muscles pressure time product (PTPmus) between 50 and 150 cm H2O • s / min.